µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º N
4,w
$1UN?(r
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ ,
:kCt=4%
VDQ&BmJE
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) ][0HJG{{g
@];Xbbw+c
1. ICAM-1
J/
rQ42d
vmmu[v
2. interleukin 12(IL-12) iAXx`>}m
dn`#N^Od
3. tumor infiltrating lymphocyte B"{CWH O
~%sDQt\S
4. TCR/CD3 complex ^(6.P)$
geT<vh Z6
5. hematopoietin receptor family guf+AVPno
y6G[-?"/Q
6. individual idiotype(IdI) cvc.-7IO
,',fO?Qv'
7. integrin ^TB%| yZ _
)_f
"[m%
8. colony-stimulatory factor (CSF) \WZ00Y,*
>r{,$)H0
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ^mG-O
R':a,6O
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? +n%WmRf6!
&;C|=8eB
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ ;1F3.ibE
k deJB-
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠTNiF
l hq
"esV#%:#J
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£
t1Cyyb
Ak|jJ
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) 9/Q5(P
\t )Zk2
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ *y.KD4@{
Hh;7
hY\
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) 9I.="b=J)
"rkP@ja9n
3. immunoglobulin superfamily (IgSF) ?;}2Z)
oST
Gs@EK
4. selectin z^=9
%tLJ
3<?(1kSo>>
5. anti-idiotypic antibody (¦ÁId) M-0BQs`N
?l
bK;Kv
6. major histocompatibility complex(MHC) |8V+(V
zl
-YRF^72+
7. immunotolerance V"\t
R%54!f0
%
8. biological reponse modifier(BRM) 7pr@aA"vgj
C#vU'RNpl
9. immune reponse gene (Ir gene) CA:t](xqQ
FRX'"gIR0
10. reshaped antibody (or reconstituted antibody) Y+j|T`d
JAc-5e4
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© o3j4XrK
E3sl"d;~
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ >`\~=ivrD
-bcm"(<T'
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? t"JfqD E
|a/"7B|?\
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ *|ubH?71%Y
%A:<rO85o
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? 2NqlE
->$Do$
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ l>H#\MR
-h8A<
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? E0Ig/
j
9;sebqC?
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ D3|y|Dr
68W&qzw.[r
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ F@)wi0
7 S(5\9
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? ,*wa#[
%9uLxC;
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ }&bO;o&>
QI.{M$,m~
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: 6;"jq92in*
&r;-=ASYzV
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: _>S."cm}!k
:Fm;0R@/k
̉񧄤
'n6D3Vse
Fr`"XH
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© #kR8v[Z
,Hlbl}.ls
1. CD8 Y1h8O%?
+Vl\lL
-
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) Cd?aC
96fbMP+7R
3. immunoglobulin fold(Ig fold) A9`& Wnw?
( d#E16y
4. cadherin (Ca-dependent cell adhesion moleculers) BGh1hyJ8d
iO4Yfj#?
5. idiotype-anti-idiotypic antibody immune network theory k?zw4S
k)U9%Pr
6. HLA class II antigen Q`j!$r
F%Oy4*4
7. complementarity-determining region (CDR) (S3\O `5
TmZsC5
8. perforin(or pore-forming protein ,PFP) o/I'Qi$v-
&Azfpv
9. high affinity IL-2 receptor DyhW_PH2J
Ac{"$P`
10. artificial active immunization $o2 H#"
ebsZ
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£©
cih[A2lp
!6.}{6b
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠY<0}z>^
moz*=a
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 PggjuPPh
4k%y*L
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ L{PH8Xl_
s9^r[l@W0U
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ B'[FnJ8~
1j4tR#L
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ % \N52
l5;
SY
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? :]]#X
~J
f)'mpp^
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ $>if@}u
f%ThS42
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡
^W8kt
vU(uu:U9
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ) oypl+y
z.d1>w
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ ' v)@K0P
H<N$z3k
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© HgY [Q}7s
tRC*@>I$
1. immunoglobulin gene rearrangement
vIzREu|5
gPT<%F
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) B
r`a;yT
3:]c> GPQ
3. flow cytometry(FCM) nXRT%[o
&
),!1B%
4. carrier effect WWBm*?U
\-`,fat
5. positive selection of T lymphocytes in thymus Py72:;wn
#];b+ T
6. mouse TH1(Th1) and TH2(Th2) subsets @'AjEl:&-_
a]S0|\BkN
7. perforin (pore-forming protein ,PFP) *r90IS}A$2
-xVp}RLT
8. ADCC(antibody-dependent cell-mediated cytotoxicity) P$7i>(?(
L^E#"f
9. SH-2(src-homology region 2) T1~G{@"
DWwPid}
"
10. Ab2¦Â (internal image) 7{JIHY+
`m")v0n3
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© `qs[a}%'>"
G2y`yg
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? ud
grZ/w]
\9!hg(-F
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? 2 ":W^P
b2r]>*Vc
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠDa3Z>/S
"xduh3/~=
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ =pk5'hBAi
X/BcS[a
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠmDdL7I
4K(oOxc9.
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) ]8+
D
E
(.~[-K4
ÃâÒßѧרҵ£º I83 _x|$FZ
dRL*TT0NW
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ OpD%lRl
(jp!q,)
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? vdaG?+_o
"&%Lhyt
´«È¾²¡Ñ§×¨Òµ£º H8!)zZ
&V(;zy4(R
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ Wl0p-h
/T<))@$
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ (yK@(euG
I~F]e|Ehqr
Ïû»¯×¨Òµ£º gwyX
%9
BZOB\Ym
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ AL{iQxQ6
-q30tO.
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? }eAV8LU
"F:V$,mJ
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ {,B.OM)J
7{lWg x
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 2jF}n*[OW
VDFs.;:s
1. Fas(CD95)/FasL 1hY%ZsjC
wx8Qz,Z
2. common chain of cytokine receptor
WH_
W:
>rXD Lj-e
3 . TCR/CD3 complex H X{K5 +
g(C/J9J
4. negaive selection of thymocytes T3NH8nH9"z
jqlfypU
5. artificial active immune 7J1f$5$m5
${e5Ka
6. anti-idiotypic M(1cf(<+
AC*SmQ\>!
7. IgSF wf_ $#.;m
"R\D:Olb#
8. Integrin 2UG>(R:
pVM1%n:#
9. chemokine _*cKu>,O
vdh[%T,&
10. B7/CD28 =z
TpDL
,Jx.Kj.,
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© w"O{@2B3:H
1vYa&!
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ T$sm}=
p|em_!H"SH
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ SmAii}-jf
@;tM R|p
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ X|yVRQ?F`
FOh
q&\nkU
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ $b[Ha{9(v
/A+5q\8G
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ -q(*)N5.2
FOteNQTj
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
#ro$$I;
5LZs_%#
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 4,f`C0>"
D< kf/hj
1. B7/CD28 ]E)D})r`#
7jHrLsB
2. Th1 subset NV==[$ (r
#M<YNuE#"
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© ^
Nu
j/
ysCK_
4. antibody affinity maturation Igw2n{})w
DL
d~
5. AP-1
M`7[hr
DMTc{
6. single chain variable fragment£¨ScFv£© C+>mehDC_G
8C[eHC*r
7. NK cell receptor H/k]u)Gtv
stMxlG"d
8. Zinkernagel-Doherty phenomenon vE1:;%Q
(pHJEY
9. Ig fold Ups0Xg&{
'+ mI
10. CD40/CD40L feH&Ug4?G
nf[KD,f
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© epG]$T![
-0BxZ AW=
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ 2^"!p;WQ
j+S&5C/{
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ }D`ZWTjDay
>;F}>_i
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ x>,wmk5)
S4c-
i2Rq
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ ?"T!<L
t:P7ah
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ j?T>S]xOX
}eI9me@Aa
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ mkPqxzxbrL
W#kyD)(F
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ #%8)'=1+4?
("{vbs$;
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© b|G~0[g
t;0]d7ey'
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© +2k{yl
Hwtoa,
1.Co-stimulators (or co-stimulating molecules) Cs,Cb2[
H
3pZfdh?w
2.NK-kB 9b&;4Yq!f
&~x |w6M]J
3.Immunoglobulin superfamily 6' \M:'<0e
U#sv.r/L}3
4.antigen-presenting cell (APC) ?B)e8i<[f
(&V)D?/hS
5.death domain cVarvueS
qlg.\H:W~
6.CCR and CXCR ()$m9%x
09 f;z
7.Lectin (or mitogen) tu@-+<*
(KfQ'B+
8.Clusters of differentiation, CD) uINEq{yo
iCGHcN^3
9.B7 family P1]F
0fR
J-G)mvkv
10.Cytotoxic T lymphocyte, CTL) v}z^M_eFm
Y{@foIZ
11.IL-15 and IL-15 receptor (IL-15R) 0C"2?etMx
.vIRz-S
12.MHC restriction vfVF^
WOd
'!4\H"t
13.Affinity-chromatography EpCNp FQT<
V1,~GpNx
14.Cyctosprin A, CsA nDLiER;U
?i!d00X
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ;Yg/y
dDA&\BuS
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© G[fg!vig#7
Y9%zo~]-W'
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 <K/iX%b?
!HW?/-\,O
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ MRK3Cey} %
u)/i$N
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ KEq48+j
)sK_k
U{\
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© &s\/Uq
g`"_+x'
ÃâÒßѧרҵ£º 9om}j
S6_dmTV*
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ hsI9{j]f
C6D
Eq>v
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ `{}DLaD9
SuBUhzR
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
H^$7=
Of<Vr.m{R
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) RNcnE1=
_M- PF$
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) S9qc34\^=
VlxHZ
1. ADCC(antibody dependent cell-mediated cytotoxicity) UGA``;f
bHzH0v]:
2. »·æß¾úËØ(cyclosporin) @4]dv> Z
IBh?vh
3. KIR(killer cell inhibitory receptor) &Z7 NF|
8Tp!b
%2.
4. HLDA(human leucocyte differentiation antigen) AUr~b3< 6
{9nH#yv
5. Interleukin 18(IL-18) ):5H,B+Vr&
xJ\>;$CY
6. ÕûºÏËØ(integrin) D<bHRtP
/nNrvMtv
7. Fas/FasL Tpp?(lT7r
kfkcaj4l]
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) 7KV0g1GQ
xG,L*3c{o
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) zj#8@gbh+
Q::_i"?c
10. Th1/Th2 JP6+h>ft
KhNOxMZ
11. »ùÒòÒßÃç(DNAÒßÃç) Z$Vd8U;
XWf1c ~J
12. chemokines and chemokine receptor $1bzsB|^
<;zcz[~
13. ÃâÒßÄÍÊÜ tP|ox]
_4X3g%nXl
14. ¹²´Ì¼¤·Ö×Ó H>|*D~RdT
/jd.<r=_I
15. ËÀÍö½á¹¹Óò(death domain) 4inMd![
x^6b$>1
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) ~L=? F
(aSY.#;
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? ]+@I]\S4
^ <+V[=X
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠn_P2l<F~/x
xC -&<s
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î &K-0ld(;
\@GKVssw
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ qnTW?c9Z5
VK^m]??s_
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå #0 eop>O
asKAHVT(
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ Yjh02wo
lD@`xq.M;
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) 2#xz,RM.
O
<"\G!y~
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ 0E/,l``p
4-~S"T8<u
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ H.*aVb$
2HF_kYZ
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£